Neonatal screening for biotinidase deficiency: A 30-year single center experience

[1]  B. Wolf.  Biotinidase deficiency masquerading as multiple sclerosis? , 2018, Multiple sclerosis.

[2]  S. Yılmaz,et al.  A treatable cause of myelopathy and vision loss mimicking neuromyelitis optica spectrum disorder: late-onset biotinidase deficiency , 2017, Metabolic Brain Disease.

[3]  E. Schmitt,et al.  Biotinidase deficiency mimicking neuromyelitis optica beginning at the age of 4: A treatable disease , 2017, Multiple sclerosis.

[4]  B. Wolf,et al.  Irreversibility of Symptoms with Biotin Therapy in an Adult with Profound Biotinidase Deficiency. , 2017, JIMD reports.

[5]  B. Wolf.  Biotinidase deficiency should be considered in individuals exhibiting myelopathy with or without and vision loss. , 2015, Molecular genetics and metabolism.

[6]  Arantzazu Arrospide,et al.  Cost-Effectiveness Analysis of a National Newborn Screening Program for Biotinidase Deficiency , 2015, Pediatrics.

[7]  A. Tourbah.  Biotin and demyelinating diseases – a new connection? , 2015, Multiple sclerosis.

[8]  Marco Spada,et al.  Newborn screening for galactosemia: a 30-year single center experience , 2015, World Journal of Pediatrics.

[9]  B. Wolf.  Why screen newborns for profound and partial biotinidase deficiency? , 2015, Molecular genetics and metabolism.

[10]  B. Wolf,et al.  Disorders of Biotin Metabolism , 2015 .

[11]  Kathryn M. Camp,et al.  Inborn errors of metabolism identified via newborn screening: Ten-year incidence data and costs of nutritional interventions for research agenda planning. , 2014, Molecular genetics and metabolism.

[12]  E. McLoone,et al.  Biotinidase Deficiency, Bilateral Optic Atrophy, and a Visual Field Defect , 2013, Neuro-ophthalmology.

[13]  G. Comi,et al.  Screening for later-onset Pompe's disease in patients with paucisymptomatic hyperCKemia. , 2013, Molecular genetics and metabolism.

[14]  A. Mussa,et al.  Impact of Neonatal Protein Metabolism and Nutrition on Screening for Phenylketonuria , 2008, Journal of pediatric gastroenterology and nutrition.

[15]  R. Desnick,et al.  High incidence of later-onset fabry disease revealed by newborn screening. , 2006, American journal of human genetics.

[16]  P. Rinaldo,et al.  Making the case for objective performance metrics in newborn screening by tandem mass spectrometry. , 2006, Mental retardation and developmental disabilities research reviews.

[17]  B. Wolf.  Worldwide survey of neonatal screening for biotinidase deficiency , 1991, Journal of Inherited Metabolic Disease.

[18]  William,et al.  The Metabolic and Molecular Bases of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., Childs, B., Kinzler, K. W., and Vogelstein, B., eds., 8th ed., McGraw-Hill, New-York, 2001, 7012 p., $550.00) , 2004, Biochemistry (Moscow).

[19]  B. Wolf,et al.  Hearing loss is a common feature of symptomatic children with profound biotinidase deficiency. , 2002, The Journal of pediatrics.

[20]  E. Mayatepek,et al.  Partial biotinidase deficiency is usually due to the D444H mutation in the biotinidase gene , 1998, Human Genetics.

[21]  G. Buck,et al.  Double mutation (A171T) and (D444H) is a common cause of profound biotinidase deficiency in children ascertained by newborn screening in the United States , 1998 .

[22]  G. Buck,et al.  Mutation (Q456H) is the most common cause of profound biotinidase deficiency in children ascertained by newborn screening in the United States. , 1997, Biochemical and molecular medicine.

[23]  B. Wolf,et al.  Biotinidase Deficiency a , 1985, Advances in pediatrics.

[24]  W. Nance,et al.  Neonatal screening for biotinidase deficiency: results of a 1-year pilot study. , 1986, The Journal of pediatrics.

[25]  B. Wolf,et al.  A screening method for biotinidase deficiency in newborns. , 1984, Clinical chemistry.

[26]  W. Parker,et al.  Deficient biotinidase activity in late-onset multiple carboxylase deficiency. , 1983, The New England journal of medicine.